TAINTED … STILL DECLARED … SAFE

A Perspective … Are you aware of what is not disclosed nor made transparent…?

As Pharmaceutical Use Soars, Drugs Taint Water and Wildlife … by sonia shah

With nearly $800 billion in drugs sold worldwide, pharmaceuticals are increasingly being released into the environment. The “green pharmacy” movement seeks to reduce the ecological impact of these drugs, which have caused mass bird die-offs and spawned antibiotic-resistant pathogens.

The standard that new drugs be safe for human consumption was first enshrined in U.S. regulations in 1938, after an antibacterial drug dissolved in a poisonous solvent killed 100 children. Now, armed with a range of evidence suggesting that wildlife and human health may be threatened by pharmaceutical residues that escape into waterways and elsewhere, a growing band of concerned ecotoxicologists and environmental chemists are calling for yet another standard for new medications: that they be designed to be safe for the environment.

The movement for “green pharmacy,” as it has been dubbed, has grown as new technology has allowed scientists to discern the presence of chemicals in the environment at minute concentrations, revealing the wide dispersal of human and veterinary drugs across the planet. In recent years, scientists have detected trace amounts of more than 150 different human and veterinary medicines in environments as far afield as the Arctic. Eighty percent of the U.S.’s streams and nearly a quarter of the nation’s groundwater sampled by the United States Geological Survey (USGS) has been found to be contaminated with a variety of medications.

This contamination is poised to worsen as the global appetite for medications swells. The drug industry sold $773 billion worth of drugs worldwide in 2008, more than double the amount sold in 2000, and with an aging population and ever-cheaper manufacturing, pharmaceutical production is expected to grow 4 to 7 percent annually until at least 2013. Americans bring home more than 10 prescription drugs per capita per year, consuming an estimated 17 grams of antibiotics alone — more than three times the per capita rate of consumption in European countries such as Germany. U.S. livestock consume even more, with farmers dispensing 11,000 metric tons of antimicrobial medications every year, mainly to promote the growth of animals.

Drugging our bodies inevitably drugs our environment, too, as many medications can pass through our bodies and waste treatment facilities virtually intact. And it is difficult to predict where and how unexpectedly vulnerable creatures may accrue potentially toxic doses.

For the most part these pharmaceuticals pass virtually untreated through today’s most modern advanced wastewater (sewage) treatment systems then are returned to mother nature and become part of the hydrologic cycle upon which we depend …

Oh, yes, this is water your water purveyors calls SAFE water for you … drink up

EXTERNALITIES … MINES … CONGRESS

A Perspective … Are you aware of what is not disclosed nor made transparent…?

EXTERNALITIESand they are money in the bank$ for Arizona’s mining industry while a deleterious health issue for you and me … And the best part …”we” … get to pick up the tap to clean up their me$$ … you gota love it … especially if you’re a mine owner …

PRESCOTT, Ariz. — A federal report says lands around a Prescott-area mine and adjacent smelter that are most contaminated with arsenic and lead should be cleaned up to safeguard public health.

The Environmental Protection Agency released its human health risk assessment for the Iron King Mine and the Humboldt Smelter this past week. The assessment includes soil samples from 65 off-site parcels in the town of Dewey-Humboldt. Of those parcels, data shows that 23 held a cancer risk greater than 1 in 10,000, and 36 exceeded the 99th percentile for lead. EPA officials say that means many of those properties contain levels of arsenic and lead that could increase the potential for health problems over time. It is in these areas where the EPA will consider any number of options for cleanup.

You really believe EPA … a federally controlled agency will ever make the mine$ actually pay for the environmental damage they create … especially after they lavishly contribute to electing a Congre$$ they control…?

A cutesy bedtime story this is not

A Perspective … Are you aware of what is not disclosed nor made transparent…?

A cutesy bedtime story this is not … though true it could be … but that really depends upon how “we” – that’s you and me – choose to see our reality …

True State of the Economy Spring 2010 … 04-12-2010 • Jack Gregson with Ernest Hancock

Jack Gregson uses simple (and complex) charts to explain ‘The True State of the Economy 2010′ (VIDEO)

HALLELUJAH

A Perspective … Are you aware of what is not disclosed nor made transparent…?

HALLELUJAHmaybe just maybe “we” are become aware and that’s powerful and positive …

Why Consumers, Community Groups and Investors Are Saying No to Nestle
Nestle has worked hard to convince people that the company has turned over a new leaf, but fewer folks are buying Nestle’s line or their water. … April 15, 2010 |

This past year, as more and more people joined the tens of thousands who have begun to question the value of bottled water, and as more communities began to challenge Nestlé’s attempts to gain control of water resources in their communities, Nestlé worked hard to convince individuals and communities that the company has turned over a new leaf, while also ensuring investors that the future viability of Nestlé’s bottled water business is sound. However, consumers and community groups aren’t buying Nestlé’s line, or their water, and even some investors are beginning to doubt that Nestlé’s bottled water business will be viable in a climate where more and more people are turning back to their public water systems and rejecting Nestlé and other bottlers’ efforts to sell them ‘old water in new bottles.’

Read complete article at ..

http://www.alternet.org/story/146488/why_consumers%2C_community_groups_and_investors_are_saying_no_to_nestle

BIG-PHARMA … MUSHROOMS … $$$

A Perspective … Are you aware of what is not disclosed nor made transparent…?

Ever consider that … IF … “big-pharma” – AMA – ADA – for-profit-corporate-interest$ … could make $$$ from mushrooms, marijuana or other so-call “hallucinogen$” … they would be as legal and plentiful as Ritalin is today …

Hallucinogens Have Doctors Tuning In Again … By JOHN TIERNEY … Published: April 11, 2010 …

As a retired clinical psychologist, Clark Martin was well acquainted with traditional treatments for depression, but his own case seemed untreatable as he struggled through chemotherapy and other grueling regimens for kidney cancer.

Counseling seemed futile to him. So did the antidepressant pills he tried.
“It was a whole personality shift for me. I wasn’t any longer attached to my performance and trying to control things. I could see that the really good things in life will happen if you just show up and share your natural enthusiasms with people.” CLARK MARTIN, a retired psychologist, on his participation in an experiment with a hallucinogen

Nothing had any lasting effect until, at the age of 65, he had his first psychedelic experience. He left his home in Vancouver, Wash., to take part in an experiment at Johns Hopkins medical school involving psilocybin, the psychoactive ingredient found in certain mushrooms.

Scientists are taking a new look at hallucinogens, which became taboo among regulators after enthusiasts like Timothy Leary promoted them in the 1960s with the slogan “Turn on, tune in, drop out.” Now, using rigorous protocols and safeguards, scientists have won permission to study once again the drugs’ potential for treating mental problems and illuminating the nature of consciousness.

After taking the hallucinogen, Dr. Martin put on an eye mask and headphones, and lay on a couch listening to classical music as he contemplated the universe.

“All of a sudden, everything familiar started evaporating,” he recalled. “Imagine you fall off a boat out in the open ocean, and you turn around, and the boat is gone. And then the water’s gone. And then you’re gone.”
Today, more than a year later, Dr. Martin credits that six-hour experience with helping him overcome his depression and profoundly transforming his relationships with his daughter and friends. He ranks it among the most meaningful events of his life, which makes him a fairly typical member of a growing club of experimental subjects.

Researchers from around the world are gathering this week in San Jose, Calif., for the largest conference on psychedelic science held in the United States in four decades. They plan to discuss studies of psilocybin and other psychedelics for treating depression in cancer patients, obsessive-compulsive disorder, end-of-life anxiety, post-traumatic stress disorder and addiction to drugs or alcohol.

The results so far are encouraging but also preliminary, and researchers caution against reading too much into these small-scale studies. They do not want to repeat the mistakes of the 1960s, when some scientists-turned-evangelists exaggerated their understanding of the drugs’ risks and benefits.

Because reactions to hallucinogens can vary so much depending on the setting, experimenters and review boards have developed guidelines to set up a comfortable environment with expert monitors in the room to deal with adverse reactions. They have established standard protocols so that the drugs’ effects can be gauged more accurately, and they have also directly observed the drugs’ effects by scanning the brains of people under the influence of hallucinogens.

Scientists are especially intrigued by the similarities between hallucinogenic experiences and the life-changing revelations reported throughout history by religious mystics and those who meditate. These similarities have been identified in neural imaging studies conducted by Swiss researchers and in experiments led by Roland Griffiths, a professor of behavioral biology at Johns Hopkins.

In one of Dr. Griffiths’s first studies, involving 36 people with no serious physical or emotional problems, he and colleagues found that psilocybin could induce what the experimental subjects described as a profound spiritual experience with lasting positive effects for most of them. None had had any previous experience with hallucinogens, and none were even sure what drug was being administered.

To make the experiment double-blind, neither the subjects nor the two experts monitoring them knew whether the subjects were receiving a placebo, psilocybin or another drug like Ritalin, nicotine, caffeine or an amphetamine. Although veterans of the ’60s psychedelic culture may have a hard time believing it, Dr. Griffiths said that even the monitors sometimes could not tell from the reactions whether the person had taken psilocybin or Ritalin.

The monitors sometimes had to console people through periods of anxiety, Dr. Griffiths said, but these were generally short-lived, and none of the people reported any serious negative effects. In a survey conducted two months later, the people who received psilocybin reported significantly more improvements in their general feelings and behavior than did the members of the control group.

The findings were repeated in another follow-up survey, taken 14 months after the experiment. At that point most of the psilocybin subjects once again expressed more satisfaction with their lives and rated the experience as one of the five most meaningful events of their lives.
Since that study, which was published in 2008, Dr. Griffiths and his colleagues have gone on to give psilocybin to people dealing with cancer and depression, like Dr. Martin, the retired psychologist from Vancouver. Dr. Martin’s experience is fairly typical, Dr. Griffiths said: an improved outlook on life after an experience in which the boundaries between the self and others disappear.

In interviews, Dr. Martin and other subjects described their egos and bodies vanishing as they felt part of some larger state of consciousness in which their personal worries and insecurities vanished. They found themselves reviewing past relationships with lovers and relatives with a new sense of empathy.

“It was a whole personality shift for me,” Dr. Martin said. “I wasn’t any longer attached to my performance and trying to control things. I could see that the really good things in life will happen if you just show up and share your natural enthusiasms with people. You have a feeling of attunement with other people.”
The subjects’ reports mirrored so closely the accounts of religious mystical experiences, Dr. Griffiths said, that it seems likely the human brain is wired to undergo these “unitive” experiences, perhaps because of some evolutionary advantage.

“This feeling that we’re all in it together may have benefited communities by encouraging reciprocal generosity,” Dr. Griffiths said. “On the other hand, universal love isn’t always adaptive, either.”
Although federal regulators have resumed granting approval for controlled experiments with psychedelics, there has been little public money granted for the research, which is being conducted at Hopkins, the University of Arizona; Harvard; New York University; the University of California, Los Angeles; and other places.

The work has been supported by nonprofit groups like the Heffter Research Institute and MAPS, the Multidisciplinary Association for Psychedelic Studies.

“There’s this coming together of science and spirituality,” said Rick Doblin, the executive director of MAPS. “We’re hoping that the mainstream and the psychedelic community can meet in the middle and avoid another culture war.

Thanks to changes over the last 40 years in the social acceptance of the hospice movement and yoga and meditation, our culture is much more receptive now, and we’re showing that these drugs can provide benefits that current treatments can’t.”
Researchers are reporting preliminary success in using psilocybin to ease the anxiety of patients with terminal illnesses. Dr. Charles S. Grob, a psychiatrist who is involved in an experiment at U.C.L.A., describes it as “existential medicine” that helps dying people overcome fear, panic and depression.

“Under the influences of hallucinogens,” Dr. Grob writes, “individuals transcend their primary identification with their bodies and experience ego-free states before the time of their actual physical demise, and return with a new perspective and profound acceptance of the life constant: change.”

Consider that for many thousands of years our ancestors … those we today label as primitive … utilized these ingredients provided by mother-nature in positive ways to heal and enrich their lives … and it was a gift …

Utah’s tar sand & safe water

A Perspective … Are you aware of what is not disclosed nor made transparent…?

Another Water Crisis Unfurling: Tar Sands Development Coming to Utah…?
A new project may be coming to Utah that could have significant effects on water quality and quantity. … April 14, 2010 … SolveClimate / By David Levitan

Much of the more than 2 million barrels of oil Canada sends south every day comes from the tar sands of the Athabasca region in Alberta. The ongoing tar sands boom in the area has been called an environmental crime of enormous proportions, and there are hints that some of the dirty processes required might be heading south as well, to the Uintah Basin in Utah.

Several companies have been operating small-scale projects in tar sands areas mines in Utah. Now, Earth Energy Resources has obtained the permits required to expand its site to a 62-acre mine that the company hopes will eventually produce about 2,000 barrels of oil per day.

This doesn’t compare with the enormous projects in Alberta — some of which are in the hundreds of thousands of barrels per day range — but environmentalists are concerned about the impact on Utah’s other natural resources.

“Even if it were economically viable, I think it would be extremely destructive environmentally, and we would be very eager to see the competent authorities keeping an eye on water and air quality problems,” said Mark Clemens, of the Sierra Club’s Utah Chapter.

Utah’s Tar Sands Resource …According to the Utah Geological Survey, the state has between 14 and 15 billion barrels of measured oil locked up in tar sands. When estimated resources are included, another 23 to 28 billion barrels make an appearance. For comparison, the entire U.S. used about 7 billion barrels of oil in all of 2008

YUP … it’s up t you to do something IF that’s what you want…

WOW … What a gift

A Perspective … Are you aware of what is not disclosed nor made transparent…?

WOW … What a gift Glendale gave to Reinsdorf … the taxpayers of Glendale essentially will underwrite Reinsdorf and guarantee he won’t lose money while he owns the Coyotes … where’s the risk and how the hell do I get in on that gravy train … yea, I’m just a bit green with envy…

Glendale goes with Reinsdorf, kills Ice Edge lease for Phoenix Coyotes … Tuesday, April 13, 2010, 10:14pm MST | Modified: Wednesday, April 14, 2010, 10:00am

The Glendale City Council approved a preliminary arena lease agreement Tuesday night with Chicago White Sox owner Jerry Reinsdorf, and turned down a deal with Ice Edge Holdings Inc.

The council was more comfortable with a different deal being struck with Reinsdorf. Glendale Mayor Elaine Scruggs was not at the key meeting. Scruggs is in Washington on a regional economic and lobbying trip with the Greater Phoenix Economic Council and other Valley mayors.
City Councilwoman Joyce Clark said she was disappointed Scruggs didn’t take a stance on the Coyotes deals. Glendale now will try to forge final lease deals with Reinsdorf. The Coyotes ownership saga then turns to the National Hockey League which will broker a sale of the Phoenix team before the end of June.

Clark said if a deal can’t be done with Reinsdorf, the NHL will move the team out of Glendale to another market. The NHL owns the Coyotes having bought them for $140 million in October via Chapter 11 bankruptcy proceedings.

Reinsdorf, who also owns the NBA’s Chicago Bulls, would buy the team for $103 million. Ice Edge has said they hope to buy the Coyotes for the $140 million NHL asking price. The league wants between $140 million and $160 million for the Coyotes. The team is slated to lose $20 million this season, according to NHL legal documents.

The Reinsdorf deal entails creating a special bond district around the arena and Westgate City Center that will take out bonds against property tax revenue. Those bond proceeds will be used to pay the NHL $65 million and set up a reserve fund to deal the team’s financial losses.

Reinsdorf also would manage the city-owned arena under the lease deal. Glendale Deputy City Manager Jim Colson said Reinsdorf can sell the team to an owner in another market if the bond district does not perform up to the lease deal and the team is losing money. Glendale would have the chance to find a new Arizona owner before Reinsdorf could sell the team to another market.

Ice Edge CEO Anthony LeBlanc told the council that his group is committed to keeping the team in Glendale and Reinsdorf’s bid allows an out-clause to move the team after five years.

Colson and Glendale Assistant City Manager Art Lynch said the bond district revenue in the Ice Edge transaction would back loans the group is taking out to buy the Coyotes. The Ice Edge deal includes parking charges, as well as ticket surcharges on hockey and concerts at Jobing.com Arena.

Questions have been raised about the legality of Reinsdorf’s plan and how much actual money Reinsdorf and his business partner, John Kaites, are ponying up toward their bid.

Glendale’s agreement with Reinsdorf includes new parking charges at the arena for Coyotes games of between $8 and $20 per car. Glendale Councilman Phil Lieberman voiced frustration over not getting information on the respective deals before last week and wanted to know how much rent was going to be paid, if any, by either Reinsdorf or Ice Edge.

Read more: Glendale goes with Reinsdorf, kills Ice Edge lease for Phoenix Coyotes – Phoenix Business Journal:

AWESOMEbuy a team in bankruptcy … get the city to guarantee you can’t lose $$$ with an option to walk away after 5 years if Reinsdorf doesn’t make … $$$ … question is how much is enough … $$$ … doesn’t say, it never doe$ …

DOW CHEMICAL WOULDN’T LIE…?

A Perspective … Are you aware of what is not disclosed nor made transparent…?

DOW CHEMICAL knows just as all giant for-profit-corporate-interest knows … it’s all a matter of … spin … hire the right PR firm, the right legal firm, have interest$ in mass-media and the truth can be successfully camouflaged from the public …

Dow Chemical Is Sponsoring a Run for Water . . . Activists Fight Back … Planet Green / By Rachel Cernansky … April 16, 2010

The company says it is part of its efforts to help the 1.2 billion who lack access to clean water but Dow has contaminated water supplies for many of those people. Dow Chemical is sponsoring a Live Earth Run for Water next week, which the company says is part of its efforts to help the 1.2 billion people across the globe that lack access to clean water.
Dow, however, has contaminated water supplies for many of those 1.2 billion people—it is affiliated with dioxin pollution in Michigan water (that the EPA is now paying to clean up), dolphin deaths in Texas, and horrific human injuries from South Africa to New Zealand.

The company’s reputation has also still not recovered from the Bhopal disaster, the 1984 gas leak from a pesticide plant in Bhopal, India, that killed up to 16,000 people from gas-related diseases and injured countless others. (At the time, the plant was owned by Union Carbide, which was acquired by Dow in 2001. Stockholders tried to stop the deal because of liabilities for Bhopal, but the acquisition went ahead.) More than 25 years later, 390 tons of toxic chemicals continue to leak out from the abandoned site and pollute the region’s groundwater, and Dow has not taken responsibility for the cleanup.

Dow Chemical’s legacy is not one built on full, open, timely disclosure or transparency … so … NO … I don’t trust them.

Follow

Get every new post delivered to your Inbox.